BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:VentriGel readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of VentriGel\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06461676-644@assetmemo.bio
DTSTAMP:20261121T004526Z
DTSTART;VALUE=DATE:20280930
DTEND;VALUE=DATE:20281001
SUMMARY:VentriGel: Phase 1 readout est. (NCT06461676)
DESCRIPTION:VentriGel\, phase 1.\nStudy: Study of Intramyocardial Injection
  of Ventrix Bio Extracellular Matrix (VentriGel) to Assess the Safety and 
 Feasibility in Pediatric Patients with Hypoplastic Left Heart Syndrome (HL
 HS)\nEstimated primary completion: September 2028. This is a ClinicalTrial
 s.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pag
 e: https://assetmemo.bio/drug/ventrigel#upcoming-events\nRegistry record: 
 https://clinicaltrials.gov/study/NCT06461676
URL:https://assetmemo.bio/drug/ventrigel#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
